Merck Announces $3 Billion Center of Excellence for Pharmaceutical Manufacturing in Virginia

Merck has unveiled plans for a major $3 billion investment to establish a 400,000-square-foot Center of Excellence for Pharmaceutical Manufacturing at its Elkton, Virginia site. The new facility will feature state-of-the-art manufacturing and laboratory spaces, expected to create over 500 high-paying jobs and thousands of temporary construction roles.

CEO Robert M. Davis emphasized the broader impact of the project, saying, “Today is an important milestone for Merck, for Virginia, for manufacturing in the United States and, most importantly, for the patients we serve.”

This initiative underscores Merck’s commitment to bolstering U.S.-based production capabilities, aiming to accelerate the delivery of essential medicines to global markets.